Attend the Virtual Global Study Fair | Register Now Attend the Virtual Global Study Fair | Register Now

We have 11 ovarian cancer PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


ovarian cancer PhD Projects, Programmes & Scholarships

We have 11 ovarian cancer PhD Projects, Programmes & Scholarships

PhD saved successfully

Discovering molecular targets to treat ovarian cancer

Background. Ovarian cancer is the leading cause of death from gynaecological malignancies. Subtypes with mutations in a member of the SWI/SNF (SWItch/Sucrose Non-Fermentable) chromatin remodelling complex are particularly chemoresistant. Read more

Dissecting mechanism of drug responses to novel anti-cancer therapies

Repurposing drug screens with compounds that have already gained FDA approval can accelerate the identification of new therapies to treat an illness and in the cancer setting extend life or provide compassionate care. Read more

Developing novel therapeutic strategies to better treat Triple Negative Breast Cancer

One in two people will develop cancer in their lifetime and it is a leading cause of death. While significant progress has been made in the treatment of some cancers, there still remain some forms of the disease with limited treatment options and poor outcome. Read more

New Anticancer Therapeutics Based on Luminescent Transition Metal Complexes

Cancer is one of the leading causes of death around the world. Over 50% of cancer tumours are treated with platinum-based metal complexes, like cisplatin and its derivatives. Read more

Personalising cancer treatment with modelling tumour evolution based on genomics biomarkers and PK/PD

Tumour heterogeneity is a major problem limiting the efficacy of targeted oncological therapies. Most advanced tumours eventually become resistant to the treatments, ultimately making the patient succumb to metastatic disease. Read more

Investigating the role of USP17 in EMT

USP17 is over-expressed in a range of primary tumours (NSCLC, breast, colorectal, cervical, ovarian, osteosarcoma) and its depletion blocks the growth, and migration, of cells from all of these cancer types. Read more
  • 1

Filtering Results